CITIUS ONCOLOGY, INC. 8-K

What Happened
Citius Oncology, Inc. announced its results of operations for the first quarter of fiscal 2026 via a press release dated February 13, 2026. The company filed a Form 8‑K (Item 2.02) to disclose those quarterly results and furnished the press release as Exhibit 99.1, which is incorporated by reference into the filing.

Key Details

• Filing date: February 13, 2026 (Form 8‑K, Item 2.02 - Results of Operations and Financial Condition).
• Press release: Furnished as Exhibit 99.1 and incorporated by reference.
• Technical exhibit: Cover page interactive data file submitted in iXBRL format (Exhibit 104).
• The 8‑K announces the company’s quarterly results; financial details are provided in the attached press release (Exhibit 99.1).

Why It Matters
This 8‑K signals that Citius Oncology has published its quarterly earnings-related information (earnings/quarterly results, revenue and other operating metrics) for Q1 fiscal 2026. Investors should review the Exhibit 99.1 press release and the company’s subsequent SEC filings for the full financial figures, trends (revenue, net income/loss, cash position) and any management commentary that could affect investment decisions. This is a routine disclosure under Item 2.02 rather than a change in management or a corporate transaction.